维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="DEMETS DL"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Methods for combining randomized clinical trials: Strength and limitations 显示文摘	Discussion of DeMets DL	1987	Stat Med1987，6，：	1
2	Methods for combining randomized clinical trials: strengths and limitations显示文摘	Demets DL	1987	Stat Med1987，3，：	1
3	Effect of Carrediol on Survial in severe chro- nic heart failure 显示文摘	Packer M Coats AJ Fowler MB Katus HA Krum H Mohacsi P Rouleau JL Tendera M Castaigne A Roecker EB Schultz MK DeMets DL Carvedilol Prospective Randomized Cumulative Survival Study Group	2001	N Engel J Med2001，344，22：	1
4	Methods for combining randomized clinical trials: Strengths and limitations 显示文摘	Demets DL	1987	Stat Med1987，6，3：	1
5	Methods of combining randomized clinical trials:strengths and limitations 显示文摘		1987	Statistics in Medicine1987，6，3：	1
6	The clinical features of massive and submassive pulmonary embolism显示文摘	Bell WR Simon TL Demets DL	1977	Am J Med1977，62，：	1
7	The data and safety monitoring board and acquired immune deficiency syn- drome (AIDS) clinical trials显示文摘	DEMETS DL FLEMING TR WHITLEY RJ	1995	Control Clin Trials1995，16，6：	1
8	Statistical aspects of early termination in the beta-blocker heart attack trial 显示文摘	DeMets DL Hardy R Friedman LM Lan KK	1984	Control Clin Trials1984，5，：	1
9	Considerations in the evaluation of surrogate endpoints in clinical trials, summary of a National Institutes of Health workshop 显示文摘	De Gruttola VG Clax P DeMets DL	2001	Control Clin Trials2001，22，5：	1
10	Discrete sequential boundaries for clinical trials显示文摘	Lan KKG DeMets DL	1983	Biometrika1983，70，：	1
11	Desing and analysis of group sequential tests based on the type I error spending rate function 显示文摘	Lan KK & Demets DL	1987	Biometrika1987，74，：	1
12	Surrogate end points in clinical trials: are we being misled? 显示文摘	FLEMING TR DEMETS DL	1996	Ann Intern Med1996，125，：	1
13	Computations for group sequential boundaries using the Lan-Demets spending function method 显示文摘	Lan KK Demets DL	2000	Controlled Clinical Trials2000，21，：	1
14	Monitoring mortality at interim analyses while testing a composite endpoint at the final analysis显示文摘	Chen YH DeMets DL Lan KK	2003	Control Clin Trials2003，24，：	1
15	Liability issues for data monitoring committee members显示文摘	DeMets DL Fleming TR Rockhold F et aI	2004	Clin Trials2004，1，6：	1
16	Surrogate end points in clinical trials:Are we been misled? 显示文摘	Fleming TR Demets DL	1996	Ann Intern Med1996，125，：	1
17	Monitoring of clinical trials: issues and recommendations显示文摘	Fleming TR DeMets DL	1993	Control Clin Trials1993，14，：	1
18	Surrogate end points in clinical trials: are we being mislead?显示文摘	Fleming TR DeMets DL	1996	Ann Intern Med1996，125，7：	1
19	Discrete sequential boundaries for clinical trials显示文摘	Lan KK DeMets DL	1983	Biometrika1983，70，：	1
20	Monitoring clinical trials: issues and recommendations 显示文摘	Fleming TR DeMets DL	1993	Control clin trials1993，14，3：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示